• Sudha Sivaram, Gautam Majumdar, Douglas Perin, Ashrafun Nessa, Mireille Broeders, Elsebeth Lynge, Mona Saraiya, Nereo Segnan, Rengaswamy Sankaranarayanan, Preetha Rajaraman, Edward Trimble, Stephen Taplin, G K Rath, and Ravi Mehrotra.
• Public Health Research Branch, Center for Global Health, US National Cancer Institute, Rockville, MD, USA. Electronic address: sudha.sivaram@nih.gov.
• Lancet Oncol. 2018 Feb 1; 19 (2): e113e122e113-e122.

AbstractThe reductions in cancer morbidity and mortality afforded by population-based cancer screening programmes have led many low-income and middle-income countries to consider the implementation of national screening programmes in the public sector. Screening at the population level, when planned and organised, can greatly benefit the population, whilst disorganised screening can increase costs and reduce benefits. The International Cancer Screening Network (ICSN) was created to share lessons, experience, and evidence regarding cancer screening in countries with organised screening programmes. Organised screening programmes provide screening to an identifiable target population and use multidisciplinary delivery teams, coordinated clinical oversight committees, and regular review by a multidisciplinary evaluation board to maximise benefit to the target population. In this Series paper, we report outcomes of the first regional consultation of the ICSN held in Agartala, India (Sept 5-7, 2016), which included discussions from cancer screening programmes from Denmark, the Netherlands, USA, and Bangladesh. We outline six essential elements of population-based cancer screening programmes, and share recommendations from the meeting that policy makers might want to consider before implementation.Copyright © 2018 Elsevier Ltd. All rights reserved.

21 keywords...

hide…